References
- Dent KM, Kenneson A, Palumbos JC, et al. Methodology of a multistate study of congenital hearing loss: preliminary data from Utah newborn screening. Am J Med Genet C Semin Med Genet. 2004;125C:28–34.
- Shi Xun B, Wu N, Guo Wei W, et al. Application of adeno-associated virus to gene therapy of hereditary non-syndromic sensorineural hearing loss. Chin J Otol. 2016;14:37–42.
- Izumikawa M, Minoda R, Kawamoto K, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 2005;11:271–276.
- Askew C, Rochat C, Pan B, et al. Tmc gene therapy restores auditory function in deaf mice. Sci Transl Med. 2015;7:295ra108.
- Chen W, Chen L, Yang Shi M. Exploration and application of hereditary auditorily handicaped family of Rongchang pig. Chin J Otol. 2016;14:10–14.
- Vodicka P, Smetana K Jr, Dvoránková B, et al. The miniature pig as an animal model in biomedical research. Ann NY Acad Sci. 2005;1049:161–171.
- Hu Wei X. Medical molecular biology. 2nd ed. Beijing: Science Press; 2014.
- Wu N, Li M, Chen ZT, et al. In vivo delivery of Atoh1 gene to rat cochlea using a dendrimer-based nanocarrier. J Biomed Nanotechnol. 2013;9:1736–1745.
- Zhao Lin Q, Xi B, Peng Hua S. Research progresses on adeno-associated virus vectors. Curr Biotechnol. 2012;2:110–115.
- Luebke AE, Rova C, Von Doersten PG, et al. Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies. Adv Otorhinolaryngol. 2009;66:87–98.
- Yu Zi L, Han De M, Wang Ruo F. Progress of gene therapy in sensorinural hearing loss. Chin Arch Otolaryngol Head Neck Surg. 2001;8:185–188.
- Dong Xiao Y. Research on new adeno-associated virus vectors and applications. Shanghai: Eye & ENT Hospital of Fudan University; 2010.
- Kilpatrick LA, Li Q, Yang J, et al. Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear. Gene Ther. 2011;18:569–578.
- Akil O, Seal RP, Burke K, et al. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron. 2012;75:283–293.
- Chang Q, Wang J, Li Q, et al. Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange-Nielsen deafness syndrome. EMBO Mol Med. 2015;7:1077–1086.
- Liu Y, Okada T, Sheykholeslami K, et al. Specific and efficient transduction of cochlear inner hair cells with recombinant adeno-associated virus type 3 vector. Mol Ther. 2005;12:725–733.
- Xu L, Daly T, Gao C, et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther. 2001;12:563–573.
- Jero J, Mhatre AN, Tseng CJ, et al. Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther. 2001;12:539–548.
- Shibata SB, Di Pasquale G, Cortez SR, et al. Gene transfer using bovine adeno-associated virus in the guinea pig cochlea. Gene Ther. 2009;16:990–997.
- Chen W, Liu Ri Y, Zhang L, et al. Electronic cochlea transformation of Rongchang pig and preliminary observation of auditory functions. Chin J Otol. 2016;14:15–20.